The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-29
DOI
10.3389/fcell.2021.655307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling
- (2021) Sina V Barysch et al. EMBO REPORTS
- Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells
- (2020) Hasan Onur Caglar et al. MOLECULAR BIOLOGY REPORTS
- Interferon Regulatory Factor-2 Binding Protein 2 Ameliorates Sepsis-Induced Cardiomyopathy via AMPK-Mediated Anti-Inflammation and Anti-Apoptosis
- (2020) Tianyu Li et al. INFLAMMATION
- Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression
- (2020) Jichao He et al. ONCOGENE
- Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy
- (2020) Wei Wang et al. Cells
- Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
- (2020) Ying-Hsia Chu et al. MODERN PATHOLOGY
- Durable clinical response to crizotinib in IRF2BP2-NRTK1 non-small cell lung cancer
- (2019) Buhai Wang et al. Clinical Lung Cancer
- Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish definitive myelopoiesis
- (2019) Luxiang Wang et al. HAEMATOLOGICA
- IRF2BP2 Modulates the Crosstalk between Glucocorticoid and TNF Signaling
- (2019) A.B.M. Kaiser Manjur et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The novel tumor suppressor IRF2BP2 regulates Hippo pathway in liver cancer via a feedback loop
- (2019) Xue Feng et al. HEPATOLOGY
- Down‐regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor
- (2019) Yangyang Yao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review
- (2019) Yiping Liu et al. OncoTargets and Therapy
- IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid
- (2018) Samir Mazharuddin et al. LEUKEMIA & LYMPHOMA
- Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)
- (2018) Shijian Zhang et al. Oncology Letters
- Loss of VGLL4 suppresses tumor PD‐L1 expression and immune evasion
- (2018) Ailing Wu et al. EMBO JOURNAL
- Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury
- (2017) Shelly A. Cruz et al. Frontiers in Cellular Neuroscience
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care
- (2017) Aswin Hari et al. Scientific Reports
- New variant of acute promyelocytic leukemia withIRF2BP2-RARAfusion
- (2016) Yoshimitsu Shimomura et al. CANCER SCIENCE
- IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering
- (2016) Cristiane Sécca et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia
- (2016) J V Jovanovic et al. LEUKEMIA
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to AtherosclerosisNovelty and Significance
- (2015) Hsiao-Huei Chen et al. CIRCULATION RESEARCH
- Identification of a Novel Fusion Gene,IRF2BP2-RARA, in Acute Promyelocytic Leukemia
- (2015) C. Cameron Yin et al. Journal of the National Comprehensive Cancer Network
- Control of developmentally primed erythroid genes by combinatorial co-repressor actions
- (2015) Ralph Stadhouders et al. Nature Communications
- Mutational analysis of primary central nervous system lymphoma
- (2015) Aurélie Bruno et al. Oncotarget
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
- (2014) Hatem Soliman et al. PLoS One
- Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
- (2013) Linn Fagerberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Chromatin modifiers and remodellers: regulators of cellular differentiation
- (2013) Taiping Chen et al. NATURE REVIEWS GENETICS
- Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma
- (2012) Kaja B. Nyquist et al. PLoS One
- A Novel Transcription Complex That Selectively Modulates Apoptosis of Breast Cancer Cells through Regulation of FASTKD2
- (2011) K. T. Yeung et al. MOLECULAR AND CELLULAR BIOLOGY
- Interferon Regulatory Factor 2 Binding Protein 2 Is a New NFAT1 Partner and Represses Its Transcriptional Activity
- (2011) F. R. G. Carneiro et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of a Phosphorylation-Dependent Nuclear Localization Motif in Interferon Regulatory Factor 2 Binding Protein 2
- (2011) Allen C. T. Teng et al. PLoS One
- IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
- (2010) Allen C. T. Teng et al. FASEB JOURNAL
- Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
- (2009) S. Blotta et al. BLOOD
- Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells
- (2009) Alexander A. Tinnikov et al. CANCER RESEARCH
- Targeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor Growth
- (2008) Sandra Ryeom et al. CANCER CELL
- The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response
- (2008) Max Koeppel et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation